SCHEMBL13987341

SCHEMBL13987341

COc1ccccc1CCN(C)CCCCCC(=O)c1cc2c3c(c1)CCC(=O)N3CCC2

nearest known ligand 0.59

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACHE P22303 1/20 0.47
SIGMAR1 Q99720 1/20 0.45
NPC1 O15118 1/20 0.43
TTR P02766 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13987328 0.99 ACHE (0.47) ACHESIGMAR1NPC1TTR
Hydrochloric Acid SCHEMBL4912555 0.98 ACHE (0.47) ACHESIGMAR1NPC1TTR
SCHEMBL13987315 0.96 NPC1 (0.48) ACHESIGMAR1NPC1TTR
SCHEMBL13987287 0.95 TDP1 (0.47) ACHESIGMAR1
SCHEMBL13987309 0.95 NPC1 (0.49) ACHESIGMAR1NPC1TTR
Hydrochloric Acid SCHEMBL4851823 0.94 TDP1 (0.46) ACHESIGMAR1
SCHEMBL13987253 0.94 TDP1 (0.47) ACHESIGMAR1
Hydrochloric Acid SCHEMBL4860554 0.93 TDP1 (0.47) ACHESIGMAR1
SCHEMBL13987349 0.91 ACHE (0.48) ACHE
SCHEMBL13987350 0.90 ACHE (0.44) ACHENPC1TTR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed
US-7462628-B2 Preventives/remedies for urinary disturbance TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-09 US disclosed